Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on cortisol and sleep quality of hemodialysis patients
IRCT20180117038418N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in chronic kidney disease (CKD) and sleep disorder, sponsored by Golestan University of Medical Sciences. Primary endpoints: Cortisol level change and Sleep quality. Started Jan 2018; status: completed.
02
Drugs
melatonin
03
Conditions
chronic kidney disease (CKD)sleep disorder
Beyond the preview
Go deeper on IRCT20180117038418N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180117038418N1.